Expand VIR Menu
VIR MENU

VIR Stock Summary and Trading Ideas (Vir Biotechnology | NASDAQ:VIR)

Charts for Today's Stock Price and Implied Volatility in Vir Biotechnology

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for VIR by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Vir Biotechnology (VIR) Frequently Asked Questions

What does Vir Biotechnology do?

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

What symbol and exchange does Vir Biotechnology stock trade?

Vir Biotechnology trades on the NASDAQ stock market under the symbol VIR.

What is Vir Biotechnology stock price doing today?

As of May 13, 2024, VIR stock price climbed to $9.73 with 316,934 million shares trading.

What is Vir Biotechnology's Beta?

VIR has a beta of 1.68, meaning it tends to be more sensitive to market movements. VIR has a correlation of 0.09 to the broad based SPY ETF.

How much is Vir Biotechnology worth?

VIR has a market cap of $1.32 billion. This is considered a Small Cap stock.

What is the highest and lowest price Vir Biotechnology traded in the last 3 year period?

In the last 3 years, VIR stock traded as high as $58.00 and as low as $7.61.

What are the top ETFs holding Vir Biotechnology?

The top ETF exchange traded funds that VIR belongs to (by Net Assets): IJR, VTI, XBI, VB, IWM.

Is Vir Biotechnology (VIR) a good investment?

VIR stock has underperformed the market in the last year with a return of -60.2%, while SPY returned +27.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in VIR shares. However, VIR has outperformed the market in the last 3 month and 2 week periods, returning +4.7% and +18.2%, while SPY returned +4.2% and +2.5%, respectively. This indicates VIR has been having a stronger performance recently.

What is the support and resistance for Vir Biotechnology (VIR) stock price?

VIR support price is $9.14 and resistance is $9.74 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VIR stock will trade within this expected range on the day.